Metraipolis › archive › dc_bbc8b5ee282d

Anjiang formula inhibits PVN microglial activation and lowers blood pressure by targeting RhoA/ROCK2 pathway: a retrospective clinical and experimental study — Europe PMC PMID:41800080

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41800080
DOI: 10.3389/fphar.2026.1795297
License (as archived): solo-consultazione
Archived: 2026-11-05T15:20:10.395Z
SHA-256 of the archived text: 27bf8fcaa480293d7443cadbdec756abfa3f62fe1d646434a7403e115a968f87
Stable URL of this page: https://metraipolis.com/documento/dc_bbc8b5ee282d

How to cite

Anjiang formula inhibits PVN microglial activation and lowers blood pressure by targeting RhoA/ROCK2 pathway: a retrospective clinical and experimental study — Europe PMC PMID:41800080 — Europe PMC (en), https://europepmc.org/article/MED/41800080 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbc8b5ee282d (Metraipolis archive dc_bbc8b5ee282d, sha256 27bf8fcaa480293d7443cadbdec756abfa3f62fe1d646434a7403e115a968f87)

BibTeX

@misc{dcbbc8b5ee282d,
  title = {Anjiang formula inhibits PVN microglial activation and lowers blood pressure by targeting RhoA/ROCK2 pathway: a retrospective clinical and experimental study — Europe PMC PMID:41800080},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41800080},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbc8b5ee282d; sha256 27bf8fcaa480293d7443cadbdec756abfa3f62fe1d646434a7403e115a968f87},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41800080. Agents can read the archived copy with the MCP tool read_document.